相似文献
1
Patients with rheumatoid arthritis in clinical care.
Ann Rheum Dis. 2004 Mar;63(3):221-5. doi: 10.1136/ard.2003.012575.
2
Defining remission in rheumatoid arthritis: what is it? Does it matter?
J Rheumatol. 2004 Jan;31(1):1-4.
3
Introduction: ‘Why is there persistent disease despite aggressive therapy of rheumatoid arthritis?’.
Arthritis Res Ther. 2014;16(3):113. doi: 10.1186/ar4592.
4
Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective.
Clin Exp Rheumatol. 2018 Sep-Oct;36(5):935-936. Epub 2018 Mar 21.
5
Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets.
Nat Rev Rheumatol. 2019 Nov;15(11):633-634. doi: 10.1038/s41584-019-0279-6.
6
Initial management of rheumatoid arthritis.
Rheum Dis Clin North Am. 2012 May;38(2):311-25. doi: 10.1016/j.rdc.2012.05.003.
7
Rheumatoid arthritis management options for 2012.
Cardiovasc J Afr. 2012 Jul;23(6):355.
8
The changing face of rheumatoid arthritis: sustained remission for all?
Nat Rev Immunol. 2010 Aug;10(8):605-11. doi: 10.1038/nri2804.
9
Rheumatoid arthritis: defining remission in patients with RA in clinical practice.
Nat Rev Rheumatol. 2012 Aug;8(8):445-7. doi: 10.1038/nrrheum.2012.111. Epub 2012 Jul 3.
10
Reply to: very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study.
Ann Rheum Dis. 2012 Dec;71(12):e1. doi: 10.1136/annrheumdis-2012-202480. Epub 2012 Sep 22.
引用本文的文献
1
Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose?
RMD Open. 2024 Mar 4;10(1):e003972. doi: 10.1136/rmdopen-2023-003972.
2
Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.
Front Immunol. 2020 Oct 6;11:579228. doi: 10.3389/fimmu.2020.579228. eCollection 2020.
3
Serum Peptidomic Profile as a Novel Biomarker for Rheumatoid Arthritis.
Int J Rheumatol. 2020 Aug 3;2020:6069484. doi: 10.1155/2020/6069484. eCollection 2020.
4
Proteomics in Rheumatoid Arthritis Research.
Immune Netw. 2015 Aug;15(4):177-85. doi: 10.4110/in.2015.15.4.177. Epub 2015 Aug 26.
5
Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.
Arthritis Res Ther. 2015 Aug 20;17(1):219. doi: 10.1186/s13075-015-0716-0.
6
Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts.
Semin Arthritis Rheum. 2014 Oct;44(2):131-44. doi: 10.1016/j.semarthrit.2014.05.003. Epub 2014 May 9.
7
The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound.
Ann Rheum Dis. 2013 May;72(5):665-71. doi: 10.1136/annrheumdis-2012-201469. Epub 2012 Jun 7.
8
What is the clinical relevance of erosions and joint space narrowing in RA?
Nat Rev Rheumatol. 2012 Jan 17;8(2):117-20. doi: 10.1038/nrrheum.2011.202.
9
Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.
Rheumatology (Oxford). 2010 Aug;49(8):1570-7. doi: 10.1093/rheumatology/keq131. Epub 2010 May 5.
10
Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis.
Arthritis Res Ther. 2010;12(2):R41. doi: 10.1186/ar2950. Epub 2010 Mar 11.
本文引用的文献
1
A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures.
Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S209-10.
2
A simplified disease activity index for rheumatoid arthritis for use in clinical practice.
Rheumatology (Oxford). 2003 Feb;42(2):244-57. doi: 10.1093/rheumatology/keg072.
3
Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.
J Rheumatol. 2002 Nov;29(11):2278-87.
4
5
Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis.
Arthritis Rheum. 2002 May;46(5):1155-9. doi: 10.1002/art.10195.
6
Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
Ann Rheum Dis. 2002 Jul;61(7):630-4. doi: 10.1136/ard.61.7.630.
7
How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion.
Arthritis Rheum. 2002 Apr 15;47(2):215-8. doi: 10.1002/art.10181.
8
Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis.
Arthritis Rheum. 2002 Apr 15;47(2):181-8. doi: 10.1002/art.10266.
9
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.
Arthritis Rheum. 2002 Mar;46(3):785-92. doi: 10.1002/art.10097.
10
Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.
Ann Rheum Dis. 2002 Apr;61(4):290-7. doi: 10.1136/ard.61.4.290.
Zotero 插件